Paldeep Atwal

Dr. Paldeep Atwal

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Redox Biology
Verified
Journal Article
Open access
DFDamian N Di Florio
Damian N Di Florio
JSJon Sin
Jon Sin
MCMichael J. Coronado
Michael J. Coronado
PAPaldeep Atwal
Paldeep Atwal
DFDeLisa Fairweather
DeLisa Fairweather
Autoimmune diseases are characterized by circulating antibodies and immune complexes directed against self-tissues that result in both systemic and organ-specific inflammation and pathology. Most autoimmune diseases occur more often in women than men. One exception is myocarditis, which is an inflammation of the myocardium that is typically caused by viral infections. Sex differences in the immune response and the role of the sex hormones estrogen and testosterone are well established based on animal models of autoimmune viral myocarditis as well as in mitochondrial function leading to reactive oxygen species production. RNA viruses like coxsackievirus B3, the primary cause of myocarditis in the US, activate the inflammasome through mitochondrial antiviral signaling protein located on the mitochondrial outer membrane. Toll-like receptor 4 and the inflammasome are the primary signaling pathways that increase inflammation during myocarditis, which is increased by testosterone. This review describes what is known about sex differences in inflammation, redox biology and mitochondrial function in the male-dominant autoimmune disease myocarditis and highlights gaps in the literature and future directions.

1 April 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PBPatrick R. Blackburn
Patrick R. Blackburn
ZXZhi Xu
Zhi Xu
KTKathleen E. Tumelty
Kathleen E. Tumelty
RZRose W. Zhao
Rose W. Zhao
WMWilliam J. Monis
William J. Monis
PAPaldeep Atwal
Paldeep Atwal

8 January 2014 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
FKFrank J. Kaiser
Frank J. Kaiser
MAMorad Ansari
Morad Ansari
DBDiana Braunholz
Diana Braunholz
MGMaría Concepción Gil-Rodríguez
María Concepción Gil-Rodríguez
CDChristophe Decroos
Christophe Decroos
MDMatthew A. Deardorff
Matthew A. Deardorff
Cornelia de Lange syndrome (CdLS) is a multisystem genetic disorder with distinct facies, growth failure, intellectual disability, distal limb anomalies, gastrointestinal and neurological disease. Mutations in NIPBL, encoding a cohesin regulatory protein, account for >80% of cases with typical facies. Mutations in the core cohesin complex proteins, encoded by the SMC1A, SMC3 and RAD21 genes, together account for ∼5% of subjects, often with atypical CdLS features. Recently, we identified mutations in the X-linked gene HDAC8 as the cause of a small number of CdLS cases. Here, we report a cohort of 38 individuals with an emerging spectrum of features caused by HDAC8 mutations. For several individuals, the diagnosis of CdLS was not considered prior to genomic testing. Most mutations identified are missense and de novo. Many cases are heterozygous females, each with marked skewing of X-inactivation in peripheral blood DNA. We also identified eight hemizygous males who are more severely affected. The craniofacial appearance caused by HDAC8 mutations overlaps that of typical CdLS but often displays delayed anterior fontanelle closure, ocular hypertelorism, hooding of the eyelids, a broader nose and dental anomalies, which may be useful discriminating features. HDAC8 encodes the lysine deacetylase for the cohesin subunit SMC3 and analysis of the functional consequences of the missense mutations indicates that all cause a loss of enzymatic function. These data demonstrate that loss-of-function mutations in HDAC8 cause a range of overlapping human developmental phenotypes, including a phenotypically distinct subgroup of CdLS.

1 September 2014 in Genetics in Medicine
Verified
Journal Article
Closed access
PAPaldeep Atwal
Paldeep Atwal
MBMarie-Louise Brennan
Marie-Louise Brennan
RCRachel Cox
Rachel Cox
MNMichael Niaki
Michael Niaki
JPJulia Platt
Julia Platt
LHLouanne Hudgins
Louanne Hudgins

Verified
Journal Article
Open access
PDF file
AJAngita Jain
Angita Jain
NNNadine Norton
Nadine Norton
KBKatelyn Ann Bruno
Katelyn Ann Bruno
LCLeslie T. Cooper
Leslie T. Cooper
PAPaldeep Atwal
Paldeep Atwal
DFDeLisa Fairweather
DeLisa Fairweather
Dilated cardiomyopathy (DCM) is characterized by dilatation of the left ventricle and impaired systolic function and is the second most common cause of heart failure after coronary heart disease. The etiology of DCM is diverse including genetic pathogenic variants, infection, inflammation, autoimmune diseases, exposure to chemicals/toxins as well as endocrine and neuromuscular causes. DCM is inherited in 20–50% of cases where more than 30 genes have been implicated in the development of DCM with pathogenic variants in TTN (Titin) most frequently associated with disease. Even though male sex is a risk factor for heart failure, few studies have examined sex differences in the pathogenesis of DCM. We searched the literature for studies examining idiopathic or familial/genetic DCM that reported data by sex in order to determine the sex ratio of disease. We found 31 studies that reported data by sex for non-genetic DCM with an average overall sex ratio of 2.5:1 male to female and 7 studies for familial/genetic DCM with an overall average sex ratio of 1.7:1 male to female. No manuscripts that we found had more females than males in their studies. We describe basic and clinical research findings that may explain the increase in DCM in males over females based on sex differences in basic physiology and the immune and fibrotic response to damage caused by mutations, infections, chemotherapy agents and autoimmune responses.